首页> 外文期刊>Inflammation research: Official journal of the European Histamine Research Society >Common variants of genes encoding TLR4 and TLR4 pathway members TIRAP and IRAK1 are effective on MCP1, IL6, IL1 beta, and TNF alpha levels in type 2 diabetes and insulin resistance
【24h】

Common variants of genes encoding TLR4 and TLR4 pathway members TIRAP and IRAK1 are effective on MCP1, IL6, IL1 beta, and TNF alpha levels in type 2 diabetes and insulin resistance

机译:编码TLR4和TLR4途径构件Tirap和Irak1的常见变体在McP1,IL6,IL1β和2型糖尿病和胰岛素抵抗的TNFα水平上有效

获取原文
获取原文并翻译 | 示例
           

摘要

Objective and designType 2 diabetes is a pandemic disease characterized by hyperglycemia, ineffective insulin use, and insulin resistance and affecting 1 in 11 people worldwide. Inflammation-related insulin resistance is thought to play an important role in the etiology of the disease. TLR4 is the central receptor of the natural immune system and has an important role as a trigger of the inflammatory response. The IRAK1 and TIRAP are members of the TLR4 pathway and involved in the TLR4-mediated inflammatory response. Genetic variants in the TLR4 gene or in the IRAK1 and TIRAP genes may have an important role in the development of insulin resistance and type 2 diabetes by disrupting the inflammatory response. In this direction, we aimed to investigate the relationship among TLR4 and IRAK1, TIRAP gene variants, and type 2 diabetes and insulin resistance, and investigate how these variants affect inflammatory factors (TNF-alpha, IL-6, MCP-1, and IL-1 beta).Subjects and methodsIn our study, a total of seven variations on the genes of TLR4 (rs4986790, rs4986791), IRAK1 (rs1059703, rs3027898, rs7061789), and TIRAP (rs8177374, rs8177400) were genotyped by the MassARRAY((R)) Iplex GOLD SNP genotyping in 100 type 2 diabetic patients and 100 non-diabetic individual. The TLR4 rs4986790 and rs4986791 variation was confirmed by PCR-RFLP method also. The serum IL1-beta, IL6, MCP-1, and TNF-alpha levels were measured using enzyme-linked immunosorbent assay kits.Results and conclusionAs a result of our study, no correlation was found among TLR4, IRAK1, and TIRAP gene variants and the risk of type 2 diabetes and insulin resistance. However, TNF-alpha, IL-6, MCP-1, and IL-1 beta levels were also associated with diabetes and insulin resistance (p>0.05). Although the gene variants were not significant in type 2 diabetes and insulin resistance groups, IRAK1, TLR4, and TIRAP gene variants were found to be associated with TNF-alpha, IL-6, MCP-1, and IL-1 beta levels.
机译:目的和Designtype 2糖尿病是一种大流行病,其特征在于高血糖,无效的胰岛素使用,胰岛素抵抗力,在全球11人中影响1。炎症相关的胰岛素抵抗被认为在疾病的病因中发挥着重要作用。 TLR4是天然免疫系统的中央受体,具有重要作用作为炎症反应的触发。伊拉克1和Tirap是TLR4途径的成员,并且参与TLR4介导的炎症反应。 TLR4基因或IRAK1和TiroAP基因中的遗传变体可能在胰岛素抵抗和2型糖尿病通过中断炎症反应中具有重要作用。在这个方向上,我们旨在探讨TLR4和Irak1,Tirap基因变体和2型糖尿病和胰岛素抵抗的关系,并研究这些变体如何影响炎症因子(TNF-α,IL-6,MCP-1和IL -1 beta)。我们的研究,TLR4(RS4986790,RS4986791),IRAK1(RS1059703,RS3027898,RS7061789)和Tirap(RS8177374,RS8177400)的基因共有七种变化(RSAK1 r))100型2型糖尿病患者和100名非糖尿病个体的IPLEX金SNP基因分型。通过PCR-RFLP方法确认了TLR4 RS4986790和RS4986791变异。使用酶联免疫吸附测定试剂盒测量血清IL1-β,IL6,MCP-1和TNF-α水平。结果和结论我们研究的结果,TLR4,IRAK1和TiroAP基因变体中没有发现相关性2型糖尿病和胰岛素抵抗的风险。然而,TNF-α,IL-6,MCP-1和IL-1β水平也与糖尿病和胰岛素抵抗有关(P> 0.05)。虽然基因变体在2型糖尿病和胰岛素抵抗基团中没有显着,但发现IRAK1,TLR4和TIRAP基因变体与TNF-α,IL-6,MCP-1和IL-1β水平相关。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号